Gryaznov Sergei 4
4 · MAIA Biotechnology, Inc. · Filed Aug 25, 2022
Insider Transaction Report
Form 4
Gryaznov Sergei
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2022-08-24$1.80/sh+10,000$18,000→ 34,511 total - Exercise/Conversion
Stock Options
2022-08-24−10,000→ 48,000 totalExercise: $1.80Exp: 2029-11-30→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Represents the right to buy shares of Common Stock granted pursuant to the 2018 Stock Option Plan. These options vested in four equal monthly installments beginning on December 1, 2019.